Incyte (INCY) Profit After Tax (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35% |
| Dec 31, 2025 | -29.44% |
| Sep 30, 2025 | 4.73% |
| Jun 30, 2025 | 156.00% |
| Mar 31, 2025 | -21.37% |
| Dec 31, 2024 | 89.01% |
| Sep 30, 2024 | 123.94% |
| Jun 30, 2024 | -362.23% |
| Mar 31, 2024 | -15.68% |
| Dec 31, 2023 | 17.41% |
| Sep 30, 2023 | -15.86% |
| Jun 30, 2023 | 837.88% |
| Mar 31, 2023 | -23.74% |
| Dec 31, 2022 | -74.76% |
| Sep 30, 2022 | -30.14% |
| Jun 30, 2022 | 324.91% |
| Mar 31, 2022 | -93.26% |
| Dec 31, 2021 | 210.25% |
| Sep 30, 2021 | 21.60% |
| Jun 30, 2021 | 179.17% |
| Mar 31, 2021 | -64.27% |
| Dec 31, 2020 | 1,085.66% |
| Sep 30, 2020 | -105.24% |
| Jun 30, 2020 | 140.28% |
| Mar 31, 2020 | -749.20% |
| Dec 31, 2019 | -13.46% |
| Sep 30, 2019 | 21.79% |
| Jun 30, 2019 | 2.94% |
| Mar 31, 2019 | 48.14% |
| Dec 31, 2018 | 136.71% |
| Sep 30, 2018 | -44.31% |
| Jun 30, 2018 | 227.36% |
| Mar 31, 2018 | 72.51% |
| Dec 31, 2017 | -515.01% |
| Sep 30, 2017 | 388.80% |
| Jun 30, 2017 | 93.33% |
| Mar 31, 2017 | -191.21% |
| Dec 31, 2016 | 824.81% |
| Sep 30, 2016 | -182.21% |
| Jun 30, 2016 | 208.25% |
| Mar 31, 2016 | -103.85% |
| Dec 31, 2015 | -19.08% |
| Sep 30, 2015 | 67.57% |
| Jun 30, 2015 | -120.06% |
| Mar 31, 2015 | 50.30% |
| Dec 31, 2014 | -162.31% |
| Sep 30, 2014 | 260.80% |
| Jun 30, 2014 | -8.59% |
| Mar 31, 2014 | 20.79% |
| Dec 31, 2013 | -94.54% |
| Sep 30, 2013 | -757.14% |
| Jun 30, 2013 | 83.59% |
| Mar 31, 2013 | -183.44% |
| Dec 31, 2012 | 186.50% |
| Sep 30, 2012 | -637.78% |
| Jun 30, 2012 | 108.89% |
| Mar 31, 2012 | 17.53% |
| Dec 31, 2011 | -3.77% |
| Sep 30, 2011 | -2.33% |
| Jun 30, 2011 | -95.65% |
| Mar 31, 2011 | -181.47% |
| Dec 31, 2010 | 202.65% |
| Sep 30, 2010 | -1,141.43% |
| Jun 30, 2010 | 108.52% |